Biocon Ltd.

Pro

Healthcare

08 December, 2025

True North, Tata Capital's growth PE fund stare at poor outcome from exit window

Private equity firm True North and Tata Capital Growth Fund are getting an exit window for the future from a ......

Pro

Healthcare

31 January, 2025

Abu Dhabi wealth fund ADQ signing off from India bet with a bummer

Abu Dhabi sovereign wealth fund ADQ has pressed the sell button on one of its handful of private equity-style investments ......

Premium

Healthcare

16 May, 2024

Exclusive: Poonawalla's Serum Institute forays into medtech via acquisition

Serum Institute of India (SII), the world's biggest vaccine maker, has picked up a minority stake in a medical technology company, two ......

Healthcare

14 March, 2024

ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business

Eris Lifesciences, a Mumbai-based listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, is to acquire ......

Premium

General

15 December, 2023

Grapevine: Biocon, Shriram Finance plan to sell units; Footpath Ventures eyes IPL franchise

Biocon Ltd is considering a plan to sell its generic active pharmaceutical ingredient (API) business to lower its debt, a ......

Healthcare

08 November, 2023

Eris Lifesciences acquires two businesses from Biocon arm

Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase ......

Healthcare

14 August, 2023

Biocon may list biosimilars business by 2025 first half: CEO

Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to the company's total revenue, ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......

Healthcare

25 April, 2023

Serum to double investment in PE-backed Biocon Biologics to $300 mn

A unit of Adar Poonawalla-led Serum Institute of India, the world's biggest vaccine maker, will double its investment to $300 ......

Premium

Healthcare

22 February, 2023

Kotak wraps up investments from $1 bn special situations fund with new deal

Kotak Special Situations Fund (KSSF), part of Kotak Mahindra Group’s alternative asset management arm, has completed the deployment of its ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News